Hostname: page-component-5b777bbd6c-ks5gx Total loading time: 0 Render date: 2025-06-18T12:27:36.690Z Has data issue: false hasContentIssue false
  • English
  • Français

Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial – ERRATUM

Published online by Cambridge University Press:  09 June 2025

Allan H. Young ,
Pierre-Michel Llorca ,
Andrea Fagiolini ,
Peter Falkai ,
Narcís Cardoner ,
René E. Nielsen ,
Ola Blomqvist ,
Yordan Godinov ,
Benoît Rive  and
Joris Diels
...Show all authors
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Keywords

Esketamine nasal spraysensitivity analysisquetiapine extended releasetreatment resistant depressionlong-term treatmenterratum
Type
Erratum
Information
The British Journal of Psychiatry , First View , pp. 1 - 2
Check for updates
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

In the original publication of this article, a row in Figure 2 was incorrectly labelled as ‘Odds ratio (95% CI)’:

This should have read ‘Risk Difference (95% CI)’ instead:

The article has been updated to reflect this change, and this erratum published.

Allan H. Young; Pierre-Michel Llorca; Andrea Fagiolini; Peter Falkai; Narcís Cardoner; René E. Nielsen; Ola Blomqvist; Yordan Godinov; Benoît Rive; Joris Diels; Siobhán Mulhern-Haughey; Andreas Reif

References

Young, AH, Llorca, PM, Fagiolini, A, P, Falkai, Cardoner, N, Nielsen, RE, Blomqvist, O, et al. Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial. The British Journal of Psychiatry 2025; 226(2): 72–8. https://doi.org/10.1192/bjp.2024.124.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.